Lung cancer patient’s tumor shrunk by experimental treatment
Thursday, March 26th, 2009A 49 year-old mesothelioma patient, previously given 6 months to live, just received news that her tumor has shrunk by 73 percent.
The mother of three from England participated in a clinical trial in Frankfurt, Germany, in a treatment known as chemoembolization. It introduces chemotherapy drugs directly to the tumor area through a catheter into the lung.
The patient used the compensation she received from the Ministry of Defense in England to cover the costs of the treatments. She claimed her mesothelioma was contracted by hugging her father, a dockyard worker, as a child.
The treatments, typically used in liver cancer patients, have been used on 500 patients a year. The results have had a 60% success rate, indicating that they are able to prolong the life of 60% of the patients.
To learn more about continued mesothelioma research please look through our Website. You will find information including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
